WE HAVE CHEMISTRY.

Investor news 2011-2012

25/06/2012 Chairmanship change and grant of options

14/06/2012 Director’s Shareholding

14/06/2012 Trading update

12/06/2012 RNS Reach Results of clinical study

30/04/2012 Director’s Shareholding

04/04/2012 Termination of supply arrangement

29/03/2012 Results of clinical study

12/03/2012 Interim results for the 26 weeks ended 31 December 2011

08/03/2012 Notice of results

04/01/2012 Director’s Shareholding

23/12/2011 Director’s Shareholding

21/12/2011 Grant of share options

15/12/2011 Results of the annual general meeting

08/12/2011 Director’s Shareholding

25/11/2011 Director’s Shareholding

21/11/2011 Director’s Shareholding

17/11/2011 Urology trial results confirm efficacy and cost-effectiveness of Tristel Fuse for cystoscope disinfection

11/11/2011 Director Shareholding

04/11/2011 Director Shareholding

02/11/2011 Scientific Evidence Published

24/10/2011 Tristel Directorate Change

24/10/2011 Preliminary Results for the year ended 30 June 2011

09/08/2011 Director’s Shareholding

08/08/2011 Cash inflow regarding R&D spend

29/07/2011 Grant of Patent

25/07/2011 Trading update and results date